Improvement of Doxorubicin Efficacy Using Liposomal Anti-Polo-like Kinase 1 siRNA in Human Renal Cell Carcinomas
Molecular PharmaceuticsDOI: 10.1021/mp500245z
Source: Molecular Pharmaceutics - Category: Drugs & Pharmacology Authors: Yu Sakurai, Hiroto Hatakeyama, Hidetaka Akita and Hideyoshi Harashima Source Type: research
More News: Cancer & Oncology | Carcinoma | Drugs & Pharmacology | Kidney Cancer | Renal Cell Carcinoma